Enhancing organisational innovation capability – A practice-oriented insight for pharmaceutical companies

Robb, Anna; Rohrschneider, Marc; Booth, Alex; Carter, Peggy; Walker, Richard M.; Andrews, Georgina

doi:10.1016/j.technovation.2022.102461

Cited by 16 publications

(7 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…They are more likely to integrate green technological innovation into their business development objectives, give proper support and resources, and are better able to understand the significance of low-carbon city pilots. Not only that, enterprises at higher levels of the personnel structure usually have more robust technological research and development and innovation capabilities (Robb et al, 2022), which provides these enterprises with opportunities and platforms to promote green technological innovation.…”

Section: Personnel Structure Heterogeneitymentioning

confidence: 99%

Low carbon cities pilot, executive environmental cognition, and enterprise green technology innovation

Xiao,

Dong,

Wang

2024

Manage Decis Econ

View full text Add to dashboard Cite

The potential of the low carbon city pilot (LCCP) to foster enterprise green technology innovation (EGTI) is contingent upon enhancing the quality of urban development, improving the ecological environment, and ultimately achieving the objective of “double carbon” reduction. Due to this, this article uses data from Chinese A‐share listed businesses in Shanghai and Shenzhen from 2009 to 2021 to investigate the effect of LCCP on EGTI. It is found that LCCP significantly contributes to EGTI, and a number of robustness tests later, this finding remains valid. The mechanism analysis confirms that LCCP promotes EGTI by weakening economic policy uncertainty and increasing firms' R&D investment. Through the heterogeneity analysis, this paper explores that optimizing corporate staff structure, increasing media attention, and increasing government subsidies are effective paths to promote EGTI development with LCCP. The moderating effect confirms that executives' environmental cognition plays a positive moderating role between LCCP and EGTI. This paper enriches the related research on the evaluation of the effect of low‐carbon pilots and provides important policy insights for promoting the development of corporate green transformation.

show abstract

Section: Personnel Structure Heterogeneitymentioning

confidence: 99%

Low carbon cities pilot, executive environmental cognition, and enterprise green technology innovation

Xiao,

Dong,

Wang

2024

Manage Decis Econ

View full text Add to dashboard Cite

show abstract

“…Đổi mới tổ chức được hiểu là quá trình tổ chức chấp nhận và thực hiện các ý tưởng mới, thực hiện các quy trình, sản xuất các sản phẩm hoặc dịch vụ mới 61 . Tushman và Nadler 50 nhận thấy các tổ chức có định hướng đổi mới sẽ theo đuổi và thử nghiệm các ý tưởng đổi mới; tìm kiếm cơ hội mới và chấp nhận mức độ rủi ro cao hơn.…”

Section: Giả Thuyết 2 (H 2 ): Phong Cách Lãnh đạO Chuyển đổI Có Tác đ...unclassified

Study on the relationship between transformation leadership, organizational innovation and management accounting systems in Vietnamese firms

2022

Sci. Tech. Dev. J. - Eco. Law Manag.

View full text Add to dashboard Cite

show abstract

“…In the face of evolving healthcare economics, pharmaceutical companies must innovate to meet new challenges effectively. The COVID-19 pandemic exemplified such challenges, catalyzing pharmaceutical firms to accelerate the development and deployment of therapeutic drugs and vaccines to combat the crisis [1].…”

Section: Introductionmentioning

confidence: 99%

Enhancing Competitiveness through Strategic Knowledge Sharing as a Driver of Innovation Capability and Performance

Yuen,

Lam

2024

Sustainability

View full text Add to dashboard Cite

In an era marked by global challenges, for example, the COVID-19 pandemic, the pharmaceutical sector stands at the forefront of innovation, tasked with delivering therapeutic breakthroughs at an unprecedented pace. This study ventures beyond the well-trodden path by probing the intricate dynamics of knowledge sharing as a strategic catalyst for bolstering innovation capability and performance (ICP) within pharmaceutical firms. We argue that knowledge sharing transcends conventional utility, acting as a pivotal lever that amplifies innovation within a highly regulated and competitive landscape. Through meticulous analysis, we unearth a nuanced synergy among six pivotal domains—organizational culture, managerial commitment, technological infrastructure, trust, reciprocal benefits, and knowledge dissemination. Our research model, anchored in a robust body of literature, reveals that while these elements individually support ICP, their collective orchestration through knowledge-sharing networks yields a magnified impact on innovation outcomes. We present novel insights illustrating that the interplay between these domains and knowledge-sharing practices engenders a fertile ecosystem for innovation, where diverse stakeholders contribute to richer, more robust ICP. Our findings underscore the strategic imperative for pharmaceutical firms to cultivate an integrated knowledge-sharing culture, not merely as good practice but as a cornerstone for sustained innovation and competitive superiority in a rapidly evolving industry.

show abstract

Enhancing organisational innovation capability – A practice-oriented insight for pharmaceutical companies

Cited by 16 publications

References 47 publications

Low carbon cities pilot, executive environmental cognition, and enterprise green technology innovation

Low carbon cities pilot, executive environmental cognition, and enterprise green technology innovation

Study on the relationship between transformation leadership, organizational innovation and management accounting systems in Vietnamese firms

Enhancing Competitiveness through Strategic Knowledge Sharing as a Driver of Innovation Capability and Performance

Contact Info

Product

Resources

About